Articles with "tract cancer" as a keyword



Photo by nci from unsplash

Evaluation of Racial Disparities in Quality of Care for Patients With Gastrointestinal Tract Cancer Treated With Surgery

Sign Up to like & get
recommendations!
Published in 2022 at "JAMA Network Open"

DOI: 10.1001/jamanetworkopen.2022.5664

Abstract: This cohort study examines whether racial disparities exist in treatment received and in survival among patients undergoing surgical intervention with curative intent for gastrointestinal tract cancer. read more here.

Keywords: evaluation racial; racial disparities; tract cancer; gastrointestinal tract ... See more keywords
Photo from wikipedia

Association Between Aspirin Use and Biliary Tract Cancer Survival

Sign Up to like & get
recommendations!
Published in 2019 at "JAMA Oncology"

DOI: 10.1001/jamaoncol.2019.4328

Abstract: This database study analyzes the association between aspirin use and survival in patients with biliary tract cancer. read more here.

Keywords: aspirin use; association aspirin; tract cancer; biliary tract ... See more keywords
Photo from wikipedia

Main causes of death in advanced biliary tract cancer

Sign Up to like & get
recommendations!
Published in 2023 at "Cancer Medicine"

DOI: 10.1002/cam4.5794

Abstract: There are no previous reports on the main causes of death in biliary tract cancer (BTC) patients. This study aimed to evaluate the main causes of death and survival rates in patients with BTC. read more here.

Keywords: causes death; biliary tract; main causes; tract cancer ... See more keywords
Photo from wikipedia

A multi‐institutional phase 2 trial of regorafenib in refractory advanced biliary tract cancer

Sign Up to like & get
recommendations!
Published in 2020 at "Cancer"

DOI: 10.1002/cncr.32964

Abstract: Regorafenib is an oral multikinase inhibitor targeting angiogenesis, oncogenesis, and cancer proliferation/metastasis. This study evaluated the efficacy of regorafenib in refractory biliary tract cancer (BTC) in a multi‐institutional phase 2 study. read more here.

Keywords: biliary tract; regorafenib refractory; tract cancer; multi institutional ... See more keywords
Photo from wikipedia

Postdiagnosis Aspirin Use Associated With Decreased Biliary Tract Cancer–Specific Mortality in a Large Nationwide Cohort

Sign Up to like & get
recommendations!
Published in 2021 at "Hepatology"

DOI: 10.1002/hep.31879

Abstract: Biliary tract cancer (BTC) is rare and has limited treatment options. We aimed to examine aspirin use on cancer‐specific survival in various BTC subtypes, including gallbladder cancer, ampulla of Vater cancer, and cholangiocarcinoma. read more here.

Keywords: biliary tract; tract cancer; cancer specific; aspirin use ... See more keywords
Photo from wikipedia

Letter to the Editor: Proton pump inhibitors and Biliary Tract Cancer Risk: Causality or Reverse Causality?

Sign Up to like & get
recommendations!
Published in 2021 at "Hepatology"

DOI: 10.1002/hep.32090

Abstract: We read with enormous interest the study by Kamal et al.1 For the past two decades, dispute on the carcinogenic effects of PPI has remained. In this retrospective study using nationwide registries, long-term use of… read more here.

Keywords: biliary tract; letter editor; tract cancer; causality ... See more keywords
Photo from wikipedia

Development and validation of a cancer cachexia risk score for digestive tract cancer patients before abdominal surgery

Sign Up to like & get
recommendations!
Published in 2023 at "Journal of Cachexia, Sarcopenia and Muscle"

DOI: 10.1002/jcsm.13207

Abstract: Cancer cachexia is prevalent in digestive tract cancer patients and has significant impacts on prognosis; it is vital to identify individuals who are at risk of cancer cachexia to allow for appropriate evaluation and treatment.… read more here.

Keywords: tract cancer; cancer cachexia; cancer patients; digestive tract ... See more keywords
Photo from wikipedia

Prognostic factors in patients with advanced biliary tract cancer treated with first-line gemcitabine plus cisplatin: retrospective analysis of 740 patients

Sign Up to like & get
recommendations!
Published in 2017 at "Cancer Chemotherapy and Pharmacology"

DOI: 10.1007/s00280-017-3353-2

Abstract: PurposeBiliary tract cancer (BTC) is a heterogeneous group of diseases comprising intrahepatic and extrahepatic cholangiocarcinoma and gallbladder cancer. Although gemcitabine plus cisplatin (GEMCIS) was established as the standard first-line chemotherapy based on the ABC-02 trial,… read more here.

Keywords: tract cancer; prognostic factors; first line; analysis ... See more keywords
Photo from wikipedia

Genetic polymorphisms in cyclin H gene are associated with oxaliplatin-induced acute peripheral neuropathy in South Indian digestive tract cancer patients

Sign Up to like & get
recommendations!
Published in 2018 at "Cancer Chemotherapy and Pharmacology"

DOI: 10.1007/s00280-018-3629-1

Abstract: PurposeDigestive tract cancer patients treated with oxaliplatin are often associated with the development of peripheral neuropathy. The aim of the present study is to identify the influence of single-nucleotide polymorphisms (SNPs) in genes involved in… read more here.

Keywords: tract cancer; peripheral neuropathy; cancer; cancer patients ... See more keywords
Photo from wikipedia

NUC-1031 in biliary tract cancer: from bench to bedside and back?

Sign Up to like & get
recommendations!
Published in 2020 at "Cancer Chemotherapy and Pharmacology"

DOI: 10.1007/s00280-020-04080-6

Abstract: In preclinical models of biliary tract cancer, NUC-1031 showed less potency than gemcitabine, no correlation with potential biomarkers and only moderate additive interaction in combination with cisplatin. These findings should prompt further careful pharmacological and… read more here.

Keywords: biliary tract; 1031 biliary; tract cancer; nuc 1031 ... See more keywords
Photo from wikipedia

Predictive factors of the treatment outcome in patients with advanced biliary tract cancer receiving gemcitabine plus cisplatin as first-line chemotherapy

Sign Up to like & get
recommendations!
Published in 2018 at "Journal of Gastroenterology"

DOI: 10.1007/s00535-018-1518-3

Abstract: BackgroundFew studies have clearly identified the prognostic factors in patients with advanced biliary tract cancer (BTC) receiving gemcitabine plus cisplatin (GC) which is acknowledged as standard chemotherapy regimen.ObjectivesThe aim of this study was to identify… read more here.

Keywords: biliary tract; chemotherapy; tract cancer; advanced biliary ... See more keywords